Imagine a world where a cruel disease isolates families, leaving them to face a future filled with uncertainty. For decades, Huntington's Disease (HD) was shrouded in secrecy and stigma, but the dedication of countless individuals has brought light to this darkness. Westmead Hospital's Huntington’s Disease Service recently celebrated its 30th anniversary, a testament to the unwavering commitment to supporting those affected by this devastating condition. This milestone coincided with the 50th anniversary of the Huntington support association, highlighting a half-century of advocacy and care.
Before the mid-1970s, families grappling with HD often suffered in silence. But, the tireless efforts of individuals, support groups, and healthcare professionals shattered the isolation, creating a network of support.
What exactly is Huntington's Disease? It's a rare, neurodegenerative illness that brings with it a unique set of challenges. Symptoms typically emerge between the ages of 30 and 50, subtly at first, and then gradually progressing. It impacts a person's movement, thinking processes, and emotions. The disease can transform a simple twitch into a gradual loss of mobility over many years.
Professor Clement Loy, who has directed the Westmead HD Service for the past 16 years, reflected on the service's history. He emphasized the stark reality before the 1970s, where families had little to no medical or other support. He paid special tribute to two women who were instrumental in changing this. Robyn Kapp OAM, for nearly 40 years, was the driving force behind Huntington’s NSW, the patient support association. Professor Elizabeth McCusker OAM founded the first HD clinic at Lidcombe Hospital in 1988.
When Lidcombe closed in 1995, Professor McCusker was determined to establish a multidisciplinary service to meet the complex needs of HD families. Westmead Hospital answered the call.
And this is the part most people miss... The identification of the HD-causing gene in 1993 was a pivotal moment. It opened the door for people to discover whether they had inherited the disease-causing genetic expansion. Each child of a parent with the HD gene has a 50/50 chance of inheriting the disease. Adults can undergo testing to find out if they have inherited the disease-causing genetic expansion.
The Westmead HD Service and patient organizations collaborated with geneticists and counselors to set up genetic services, helping the HD community navigate the difficult decision of genetic testing.
Today, the Westmead Hospital HD Service provides comprehensive neurological and allied health support, along with an outreach service across NSW. They are actively involved in clinical trials, observational studies, and national and international research.
The anniversary event, organized by Dr. Therese Alting and others, was a celebration of those who have dedicated their lives to improving the lives of those living with this challenging genetic condition.
Lenni Duffield, CEO of Huntington’s Australia, highlighted the importance of community support. “Finding your people and your community gives you a sense of hope, that you’re not alone, that people understand, that there’s a level of empathy, and you don’t have to consistently keep repeating your story.”
Huntington’s Australia supports those experiencing symptoms of the disease, estimated to be around 2,200 individuals in Australia, as well as those at risk, unaffected family members, and caregivers.
But here's where it gets controversial... While a cure remains elusive, significant progress has been made. Patients now benefit from symptomatic treatments, and there is considerable hope in current genetic trials.
What are your thoughts? Do you think enough resources are dedicated to rare diseases like Huntington's? Share your opinions in the comments below!
